| Basics |
| Company: |
Revance Therapeutics, Inc. |
| IPO Date: |
February 6, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$381.02M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.50 | 2.53%
|
| Avg Daily Range (30 D): |
$0.02 | 0.71%
|
| Avg Daily Range (90 D): |
$0.08 | 1.96%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.72M |
| Avg Daily Volume (30 D): |
1.78M |
| Avg Daily Volume (90 D): |
2.34M |
| Trade Size |
| Avg Trade Size (Sh.): |
117 |
| Avg Trade Size (Sh.) (30 D): |
496 |
| Avg Trade Size (Sh.) (90 D): |
330 |
| Institutional Trades |
| Total Inst.Trades: |
3,206 |
| Avg Inst. Trade: |
$1.63M |
| Avg Inst. Trade (30 D): |
$1.15M |
| Avg Inst. Trade (90 D): |
$.93M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.77M |
| Avg Closing Trade (30 D): |
$2.35M |
| Avg Closing Trade (90 D): |
$1.23M |
| Avg Closing Volume: |
97.4K |
|
|
|
|
| News |
Feb 6, 2025 @ 9:00 PM
RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 3, 2025 @ 5:00 PM
DEADLINE ALERT for NXT, RVNC, REGN, BIOA: Law Offi...
Source: Law Offices Of Howard G. Smith
|
Jan 31, 2025 @ 9:00 PM
RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Jan 24, 2025 @ 5:00 PM
DEADLINE ALERT for NXT, RVNC, REGN, BIOA: Law Offi...
Source: Law Offices Of Howard G. Smith
|
Jan 23, 2025 @ 2:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That...
Source: N/A
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.92
|
$-.37
|
$-.36
|
|
Diluted EPS
|
$-1.92
|
$-.37
|
$-.36
|
|
Revenue
|
$ 256.95M
|
$ 59.88M
|
$ 65.39M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -184.44M
|
$ -38.12M
|
$ -37.47M
|
|
Operating Income / Loss
|
$ -289.76M
|
$ -32.26M
|
$ -34.52M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -122.13M
|
$ -23.88M
|
$ -51.43M
|
|
PE Ratio
|
|
|
|
|
